Cabot Corporation $CBT Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund lessened its holdings in shares of Cabot Corporation (NYSE:CBT) by 67.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,128 shares of the specialty chemicals company’s stock after selling 89,414 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Cabot were worth $3,248,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Torren Management LLC purchased a new stake in shares of Cabot during the 4th quarter valued at approximately $26,000. Rothschild Investment LLC grew its position in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares during the period. Geneos Wealth Management Inc. lifted its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the last quarter. Global Retirement Partners LLC grew its holdings in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Cabot during the 3rd quarter worth $38,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Down 3.6%

Shares of NYSE:CBT opened at $88.24 on Friday. The firm has a 50 day simple moving average of $87.80 and a 200-day simple moving average of $79.32. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.55 billion, a PE ratio of 16.68, a P/E/G ratio of 11.91 and a beta of 0.83.

Cabot (NYSE:CBT) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.30 million. During the same period last year, the firm posted $1.90 EPS. The company’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities analysts predict that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.1%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is currently 35.73%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CBT. Mizuho boosted their price objective on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, UBS Group upped their price objective on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $85.80.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.